Table 1.
Infants exposed to rifampin (N=2500) | ||
---|---|---|
Gestational age, weeks | ||
<26 | 888 (36%) | |
26–28 | 822 (33%) | |
29–32 | 450 (18%) | |
33–36 | 203 (8%) | |
≥37 | 137 (5%) | |
| ||
Birth weight, g | ||
<1000 | 1531 (61%) | |
1000–1499 | 524 (21%) | |
1500–2499 | 252 (10%) | |
2500–3499 | 140 (6%) | |
≥3500 | 49 (2%) | |
| ||
Age at first rifampin exposure, days | ||
<3 | 5 (0.2%) | |
3–6 | 8 (0.3%) | |
7–29 | 1634 (65%) | |
30–59 | 628 (25%) | |
60–120 | 225 (9%) | |
| ||
Race/ethnicity | ||
White | 1019 (42%) | |
African American | 624 (26%) | |
Hispanic | 683 (28%) | |
Other | 95 (4%) | |
| ||
Male | 1334 (53%) | |
| ||
Caesarean delivery | 1771 (72%) | |
| ||
Mean (5th, 95th percentile) length of NICU stay, days | 85 (20, 160) | |
| ||
Died | 242 (11%) |
Abbreviation: NICU, neonatal intensive care unit.